Rotavirus-Induced Expansion of Antigen-Specific CD8 T Cells Does Not Require Signaling via TLR3, MyD88 or the Type I Interferon Receptor

被引:3
|
作者
Muleta, Konjit Getachew [1 ]
Ulmert, Isabel [2 ]
Hamza, Kedir Hussen [1 ]
van Dijl, Sharne [1 ]
Nakawesi, Joy [1 ]
Lahl, Katharina [1 ,2 ]
机构
[1] Lund Univ, Immunol Sect, Lund, Sweden
[2] Tech Univ Denmark DTU, Inst Hlth Technol, Sect Expt & Translat Immunol, Kongens Lyngby, Denmark
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
瑞典研究理事会;
关键词
rotavirus; CD8 T cells; dendritic cells; type I IFN; innate immunity; pattern (re)cognition; DENDRITIC CELLS; INFECTION; IMMUNITY; RECOGNITION; ALPHA; IL-12; MICE; IFN;
D O I
10.3389/fimmu.2022.814491
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rotavirus (RV) infection induces strong adaptive immunity. While protection from reinfection requires humoral immunity, initial clearance of infection depends on cytotoxic CD8 T cells. Type I classical dendritic cells (cDC1) excel at CD8 T cell induction through cross-presentation and are essential for optimal cytotoxicity towards RV. Upon sensing of infection-induced innate immune signals through pattern recognition receptors (PRRs), cumulating in autocrine type I interferon (IFN) signaling, cDC1 mature and migrate to the draining lymph nodes (LNs), where they prime adaptive immune cells. To analyze which PRR pathways lead to robust cytotoxicity in the context of RV infection, we measured RV-specific CD8 T cell priming in mice deficient for Toll-like receptor 3 (TLR3), recognizing double-stranded RNA, or for MyD88, the adapter for all other TLRs and IL-1 family cytokines. Individual TLR3- and MyD88-mediated signaling was not required for the priming of CD8 T cell responses to RV and neither deficiency impacted on RV clearance. Surprisingly, the accumulation of RV-specific CD8 T cells was also not altered in the absence of type I IFN signaling, while their ability to produce IFN gamma and granzyme were blunted. Together, this suggests a substantial level of redundancy in the sensing of RV infection and the translation of signals into protective CD8 T cell immunity.
引用
收藏
页数:14
相关论文
共 26 条
  • [21] Type I interferon induced by lymphotoxin-beta receptor signaling on dendritic cell is crucial for CD8 T cell infiltration into effector site by modulating the expression of tissue specific adhesion molecule VLA4
    Ng, Dennis
    Ward, Lesley
    Rahbar, Ramtin
    Cummings, Derek
    Mossman, Karen
    Ohashi, Pamela
    Gommerman, Jennifer
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [22] Type I interferon facilitates the expansion of CD4+CD25+Foxp3+regulatory T cells through upregulation of glucocorticoid-induced TNF receptor ligand on dendritic cells
    Hong, Jian
    Killian, James M.
    Liu, Xin
    Chen, Meiyue
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (08) : 1014 - 1014
  • [23] Vaccination using Toll-like receptor ligand (TLRL)-primed dendritic cells and TLR3L poly I:C administration leads to an augmentation of antigen-specific memory CD8+T cell responses
    Salem, Mohamed L.
    El-Naggar, Sabry Ali
    Kadima, Andre N.
    Diaz-Montero, Marcela C.
    Gillanders, William E.
    Cole, David J.
    CANCER RESEARCH, 2006, 66 (08)
  • [24] ANTIGEN RECOGNITION BY THE T-CELL RECEPTOR IS ENHANCED BY CD8 ALPHA-CHAIN BINDING TO THE ALPHA-3 DOMAIN OF MHC CLASS-I MOLECULES, NOT BY SIGNALING VIA THE CYTOPLASMIC DOMAIN OF CD8-ALPHA
    TANABE, M
    KARAKI, S
    TAKIGUCHI, M
    NAKAUCHI, H
    INTERNATIONAL IMMUNOLOGY, 1992, 4 (02) : 147 - 152
  • [25] The cancer-germline antigen TRAG-3 stimulates Th1-type, Toll-like receptor 8-negative antigen-specific CD4+regulatory T cells
    Kudela, Pavol
    Janjic, Bratislav
    Fourcade, Julien
    Kirkwood, John M.
    Maillere, Bernard
    Zarour, Hassane M.
    FASEB JOURNAL, 2008, 22
  • [26] The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu
    Salem, Mohamed L.
    El-Naggar, Sabry A.
    Kadima, Andre
    Gillanders, William E.
    Cole, David J.
    VACCINE, 2006, 24 (24) : 5119 - 5132